✦ LIBER ✦

POPULATION PHARMACOKINETIC STUDY OF GENTAMICIN AND A BAYESIAN APPROACH IN PATIENTS WITH RENAL IMPAIRMENT

✍ Scribed by J. M. Lanao; A. Berrocal; M. V. Calvo; M. Perez; B. de la Callet; A. Dominguez-Gil

Book ID: 114738151
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 482 KB
Volume: 14
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.1989.tb00240.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetic modelling of

Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery

✍ Christine E. Staatz; Colette Byrne; Alison H. Thomson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

A comparative study of the population ph

A comparative study of the population pharmacokinetics of gentamicin and amikacin in newborn patients

✍ M. Izquierdo; J. M. Lanao; L. Cerveró; N. V. Jiménez; A. Dominguez-Gil 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

A pharmacokinetic and safety study of in

A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment

✍ Christopher J. Sweeney; Chris Takimoto; Leslie Wood; Jennifer M. Porter; William 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 289 KB

Renal hemodynamics and pharmacokinetics

Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function

✍ Michael Solimon; Shaul G. Massry; Vito M. Campese 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 447 KB

A Pharmacokinetic Study of Plerixafor in

A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment

✍ Ronald MacFarland; Marjie L. Hard; Robert Scarborough; Karin Badel; Gary Calandr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Pharmacokinetics of nicorandil in patien

Pharmacokinetics of nicorandil in patients with normal and impaired renal function

✍ M. Molinaro; G. Villa; M. B. Regazzi; A. Salvadeo; S. Segagni; R. Rondanelli; E. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 489 KB

The pharmacokinetics of oral nicorandil 20 mg 12 hourly for 9 doses was evaluated in 21 hospitalized patients with angina pectoris due to coronary heart disease and with normal and impaired renal function. Patients were divided into 3 groups based on creatinine clearance (CLCr): GROUP I (n = 6) grea